10-K Decoder · All companies

Intellia Therapeutics, Inc.

NTLA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$67.7M$57.9M+16.9%
Operating income−$441M−$534M+17.5%
Net income−$413M−$519M+20.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$7.20M$13.8M−47.8%
Operating income−$122M−$112M−9.7%
Net income−$128M−$101M−25.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Intellia's revenue in FY2025?
$67.7M in FY2025 (Fiscal year ended Dec 31, 2025), +16.9% vs $57.9M a year earlier, per its 10-K filed Feb 2026.
Was Intellia profitable in FY2025?
No: net income was −$413M and operating income −$441M in FY2025.
What was Intellia's revenue in Q3 2026?
$7.20M (−47.8% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.